Tabrecta Breaking News Natera Enrolls First Patients in Phase III SAGITTARIUS Colon Cancer Trial MedSanTek to Distribute Bio-Techne Products in Turkey Pleno Closes $25M Series B Round, Appoints New CEO Altona Dx Gains IVDR Certification for PCR Tests, Plans to Launch 14 Tests in 2025 CareDx to Conduct Pharmacokinetic Testing in TC BioPharm's AML, MDS Cell Therapy Trial
